NASDAQ, ANGO - Angiodynamics Inc
We are a provider of innovative medical devices used in minimally invasive,
image-guided procedures to treat peripheral vascular disease, or PVD, and local
oncology therapy options for treating cancer, including radiofrequency ablation,
or RFA, and systems and embolization products for treating cancerous tumors. We
design, develop, manufacture and market a broad line of therapeutic and
diagnostic devices that enable interventional physicians (interventional
radiologists, vascular surgeons, surgical oncologists and others) to treat PVD,
tumors, and other non-coronary diseases. Unlike several of our competitors that
focus on the treatment of coronary diseases, we believe that we are the only
company whose primary focus is to offer a comprehensive product line for the
interventional treatment of these diseases.
We have been in business since 1988. Our corporate headquarters is located at
603 Queensbury Avenue, Queensbury, New York 12804. ...
Read SEC Filing on NASDAQ.com »